BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 01, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Angiox bivalirudin regulatory update

The U.K.'s NICE issued final guidance recommending Angiox bivalirudin from The Medicines Co. in combination with aspirin and clopidogrel to treat ST-segment elevation myocardial infarction (STEMI) in adults undergoing primary percutaneous coronary intervention (PCI). In June, the agency issued a...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >